Vaccines: latest news

Vaccines resources

  • Vaccines

    HIV vaccine researchers are still looking for a vaccine that would offer a significant degree of protection against HIV infection....

    From: Preventing HIV

    Information level Level 4
  • Vaccines

    The promise of an effective HIV vaccine has always been just over the horizon, but more than 20 years after the identification of HIV, vaccines...

    From: HIV transmission & testing

    Information level Level 4

Vaccines features

Vaccines news from aidsmap

More news

Vaccines news selected from other sources

  • Researcher has a radical idea for a drinkable, probiotic HIV vaccine

    Like others before him, Jean-Marie Andrieu believes he may have hit upon the long sought after HIV vaccine. And like numerous other treatments under development, the hitch is that the vaccine has only thus far only shown to be effective in protecting monkeys against the Simian Immunodeficiency Virus or SIV, the monkey equivalent to HIV.

    11 September 2014 | Washington Post (blog)
  • Gates Foundation awards $25 million to HIV vaccine research

    Researchers developing a vaccine that has shown promise in preventing HIV infection in primates said on Wednesday they have been awarded a $25 million grant from the Bill & Melinda Gates Foundation.

    05 September 2014 | Fox News
  • Scientists Question NIH Priorities in Awarding Scarce Government Grants

    One scientist says funneling large amounts of money into a single line of research, as in the search for an AIDS vaccine, rewards pet projects and leaves many researchers out in the cold.

    03 September 2014 | Healthline
  • New analysis of old HIV vaccines finds potentially protective immune response

    Applying the benefit of hindsight, researchers have reanalyzed the findings of two historic pediatric HIV vaccine trials with encouraging results. The vaccines had in fact triggered an antibody response -- now known to be associated with protection in adults -- that was previously unrecognized in the infants studied in the 1990s.

    01 September 2014 | Science Daily
  • HIV Antibodies Block Infection by Reservoir-Derived Virus in Laboratory Study

    The researchers conclude that passive immunotherapy involving bNAbs individually or in combination may control HIV in the absence of antiretroviral therapy. A number of clinical trials are already underway or planned to test this hypothesis.

    27 August 2014 | National Institutes of Allergy and Infectious Diseases press release
  • Mechanism found for development of protective HIV antibodies

    Scientists have found an immunologic mechanism that makes broadly neutralizing antibodies in people who are HIV-1 infected. The research team found that two distinct B-cell lineage antibodies teamed up to stimulate the highly sought-after broadly neutralizing antibodies to HIV. The induction of these antibodies that can neutralize a variety of HIV strains is a key strategy for a global vaccine, they say.

    22 August 2014 | Science Daily
  • HIV, HCV and TB Pipeline Report

    Drugs, diagnostics, vaccines, preventive technologies, research towards a cure, and immune-based and gene therapies in development.

    21 July 2014 | Treatment Action Group & i-Base
  • Researcher Admits to HIV Vaccine Fraud

    United States prosecutors have filed charges against a researcher who admitted to fraudulently reporting data while conducting research for a HIV vaccine. Dong-Pyou Han, a former laboratory manager at Iowa State University, admitted to putting human antibodies into samples of rabbit’s blood to create the illusion that an experimental vaccine was potentially effective. After millions in grants from the National Institutes of Health and years of work, another laboratory discovered irregularities that showed the results were false.

    26 June 2014 | Guardian Liberty Voice
  • Researchers trace HIV adaptation to its human host

    In a new study that traces the evolution of HIV in North America, researchers have found evidence that the virus is slowly adapting over time to its human hosts. However, this change is so gradual that it is unlikely to have an impact on vaccine design.

    11 June 2014 | Science Daily
  • Scripps Research Institute Scientists Find New Point of Attack on HIV for Vaccine Development

    A team led by scientists at The Scripps Research Institute (TSRI) working with the International AIDS Vaccine Initiative (IAVI) has discovered a new vulnerable site on the HIV virus. The newly identified site can be attacked by human antibodies in a way that neutralizes the infectivity of a wide variety of HIV strains.

    28 April 2014 | Scripps Research Institute
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.